<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04618172</url>
  </required_header>
  <id_info>
    <org_study_id>DRKZ01</org_study_id>
    <nct_id>NCT04618172</nct_id>
  </id_info>
  <brief_title>Effects of Aerobic Exercise on the Symptoms of Premenstrual Syndrome and Dysmenorrhoea and Blood Flow of Genital Tract</brief_title>
  <official_title>Effects of Aerobic Exercise on the Symptoms of Premenstrual Syndrome and Dysmenorrhoea and Blood Flow of Genital Tract: A Prospective Interventional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kovács Zoltán</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pecs</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effects of aerobic exercise on the symptoms of premenstrual syndrome and dysmenorrhoea and&#xD;
      blood flow of genital tract. Different self-reported questionnaires and vaginal ultrasound&#xD;
      flowmetry are used in the prospective interventional study. The study has interventional and&#xD;
      control groups. Hypothesis: The quality of life and self-awareness improve during the period&#xD;
      of study. The ultrasound examination shows changes in genital blood flow after exercise.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subject of the study:&#xD;
&#xD;
      Examination of premenstrual syndrome and dysmenorrhoea treatment results with aerobic Aviva&#xD;
      exercises.&#xD;
&#xD;
      Method of the study:&#xD;
&#xD;
      2 month-long,non-randomized, non-blind, prospective, interventional real-time comparative&#xD;
      examination performed with the participation of volunteers.&#xD;
&#xD;
      Questionnaires:&#xD;
&#xD;
        1. PRISM calendar: Prospective Record of the Impact and Severity of Menstrual Symptoms&#xD;
           (Reid, 1995). The participants have to fill out this every day,&#xD;
&#xD;
        2. The Body Awareness Questionnaire Shields, S. A., Mallory, M.E., &amp; Simon, A. (1989). The&#xD;
           Body Awareness Questionnaire: Reliability and validity. Journal of Personality&#xD;
           Assessment, 53(4), 802-815&#xD;
&#xD;
        3. Examination to measure the intensity of menstrual pain: numeric prioritization scale&#xD;
           method&#xD;
&#xD;
        4. Heart rate monitoring and documentation before and after the exercises; completion of&#xD;
           the Borg Scale of Perceived Exertion to measure exercise intensity;&#xD;
&#xD;
        5. Questionnaire of life style&#xD;
&#xD;
        6. Questionnaire of life quality: The COOP/Wonca Functional Health Assessment Charts&#xD;
&#xD;
        7. Beck depression questionnaire&#xD;
&#xD;
      Ultrasound examination:&#xD;
&#xD;
      After 1months of doing the Aviva exercises, ultrasound measurements are performed in Róbert&#xD;
      Hospital (Budapest) on the patients participating in the study. The first measurement is&#xD;
      performed for each person before starting the exercises. When the first subject has finished&#xD;
      the exercise, a control ultrasound measurement will be carried out.&#xD;
&#xD;
      In the control group there is also twice ultrasound examination for the individuals.&#xD;
&#xD;
      Measured parameters: art. uterina, art. ovarica and subendometrial blood flow - with&#xD;
      transvaginal ultrasound measurement followed by statistical evaluation of the results.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Effects of aerobic exercise on the symptoms of premenstrual syndrome and dysmenorrhoea and blood flow of genital tract. Different self-reported questionnaires and vaginal ultrasound flowmetry are used in the prospective interventional study. The study has interventional and control groups.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of premenstrual syndrome complaints</measure>
    <time_frame>Change of from baseline premenstrual syndrome complaints at 2 months</time_frame>
    <description>Rate of variation of premenstrual syndrome complaints of the participants presented in PRISM (Prospective Record of the Impact and Severity of Menstrual Symptoms) questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of dysmenorrhoea complaints</measure>
    <time_frame>Change of from baseline dysmenorrhoea complaints at 2 months</time_frame>
    <description>Rate of variation of dysmenorrhoea complaints of the participants presented in PRISM (Prospective Record of the Impact and Severity of Menstrual Symptoms) questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the genital blood flow</measure>
    <time_frame>Change of from baseline art.uterina, art.ovarica, subendometrial ultrasound flowmetry results after aerobic exercises and 30 minute long waiting time for control individuals</time_frame>
    <description>Art.uterina, art.ovarica, subendometrial ultrasound flowmetry results presented in charts</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of quality of life</measure>
    <time_frame>Change of from baseline quality of life results at 2 months</time_frame>
    <description>Change of quality of life using The COOP/Wonca Functional Health Assessment Chart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of body-mind awareness</measure>
    <time_frame>Change of from baseline body-mind awareness results at 2 months</time_frame>
    <description>Change of body-mind awareness using The Body Awareness Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence</measure>
    <time_frame>up to 2 months</time_frame>
    <description>Measurement of adherence: frequency of visiting exercising group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">113</enrollment>
  <condition>Premenstrual Syndrome</condition>
  <condition>Dysmenorrhoea</condition>
  <arm_group>
    <arm_group_label>Exercising group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group practises 30 minute long aerobic exercises twice a week besides filling out the questionnaires.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group fills out the questionnaires without practising 30 minute long aerobic exercises twice a week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aerobic exercise</intervention_name>
    <description>30 minute long aerobic exercises twice a week</description>
    <arm_group_label>Exercising group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI 17-35&#xD;
&#xD;
          -  regular menstrual cycles (cycles of 21-35 days)&#xD;
&#xD;
          -  no endocrinological disease&#xD;
&#xD;
          -  no endometriosis&#xD;
&#xD;
          -  no experience in Aviva aerob exercises&#xD;
&#xD;
          -  symptoms of premenstrual syndrome&#xD;
&#xD;
          -  symptoms of dysmenorrhoea&#xD;
&#xD;
          -  Score below 40 from Beck depression questionnaire&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  pelvic inflamatory disease (PID)&#xD;
&#xD;
          -  gynecological operation&#xD;
&#xD;
          -  failure to complete the questionnaire (3 consecutive days and 5 days interrupted)&#xD;
&#xD;
          -  dissatisfaction with the continuation of the research&#xD;
&#xD;
          -  the incidence of adverse life events in the last 3 months&#xD;
&#xD;
          -  continuous use of medication (e.g. oral birth control pill or antipsychotic tablets)&#xD;
&#xD;
          -  participation in other sports programs&#xD;
&#xD;
          -  congenital uterine anomalies&#xD;
&#xD;
          -  any chronic disease (e.g. neurological, psychological disorders, endocrinological&#xD;
             diseases)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henrik Szőke Dr, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Pecs</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Róbert Kórház</name>
      <address>
        <city>Budapest</city>
        <zip>1139</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 19, 2020</study_first_submitted>
  <study_first_submitted_qc>November 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2020</study_first_posted>
  <last_update_submitted>November 4, 2020</last_update_submitted>
  <last_update_submitted_qc>November 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Pecs</investigator_affiliation>
    <investigator_full_name>Kovács Zoltán</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Dysmenorrhea</mesh_term>
    <mesh_term>Premenstrual Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

